Gut Bacteria Molecule Linked to Atherosclerosis, Major Cause of Heart Disease
By
raphar
Front-window bakery material. Catches the eye, delivers the goods.
Summary
Spanish scientists discovered that gut bacteria produce a molecule leading to atherosclerosis, a major cause of heart attacks and strokes. The study involved Banco Santander employees in Madrid and offers new treatment possibilities beyond cholesterol reduction.
Key quotes
· 3 pulledResearchers have discovered that gut bacteria produce a molecule that not only induces but also causes atherosclerosis.
The unexpected link between microbes and cardiovascular disease opens new treatment avenues beyond cholesterol reduction.
The study involved thousands of Banco Santander employees in Madrid, providing valuable insights into the onset of heart disease in healthy individuals.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
